Terao I

Department of Psychiatry Ikokoro Clinic Nihonbashi Tokyo Japan.

3 papers · ORCID

ArticleKetamine

Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment-resistant depression: A systematic review and network meta-analysis.

Terao I, Tsuge T, Sato T +4

Europe PMC2025
ArticlePsilocybin

Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.

Terao I, Kodama W

Europe PMC2024
ArticleKetamine

Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.

Terao I, Tsuge T, Endo K +1

Europe PMC2024